DNLI · Denali Therapeutics Inc.

NasdaqHealthcareBiotechnology

Denali Therapeutics Inc Is A Biotechnology Company That Is Engaged In Developing And Discovering Therapeutics To Defeat Neurodegenerative Diseases. The Company'S Development Programs Include The Lrrk2 Inhibitor Program, Which Develops Brain Penetrant Small Molecule Lrrk2 Inhibitor Product Candidates For Parkinson'S Disease. Its Key Products Include Dnl201, Dnl151, Atv (Antibody Transport Vehicle), Etv (Enzyme Transport Vehicle), And Others. The Company Has One Operating Segment With The Goal To Discover, Develop, And Commercializing Therapeutics.

HealthcareNasdaqUS

FLOAT

133.1M

FREE FLOAT %

83%

SHARES O/S

159.8M

MARKET CAP

$2.94B

EXCHANGE

Nasdaq

COUNTRY

DNLI Catalyst History

No catalysts recorded for DNLI yet

Day Trader Sniper hasn't classified a publishable catalyst for DNLI yet. New events appear here as they're scored.

Be early on the next DNLI spark.

Day Trader Sniper alerts you the instant a setup like this triggers.

How it works Download Free →

Every Second Counts.Don't Trade Without a Real-Time sparker alert.

DNLI · Denali Therapeutics Inc.

DNLI Catalyst History

Every Second Counts.
Don't Trade Without a Real-Time sparker alert.